Group 1: Online Business Outlook - The company expects the online business profit margin to remain within a reasonable range due to improved operational capabilities and a refined operational model [2] - The online operations team has been enhanced, contributing to better profitability on online platforms [2] Group 2: Offline Business Strategy - The company has optimized offline sales channels and is expanding its sales team, anticipating a positive performance in offline business for the year [2] - The transformation of the distributor model is part of the strategy to boost offline sales [2] Group 3: Product Development and Innovation - The company is actively expanding its non-patch product line, with a focus on improving product structure and increasing the sales proportion of non-patch products [3] - A new medical device product, "Medical Trehalose Repair Patch," is planned for launch this year, following the acquisition of a Class II medical device certificate in August 2025 [3] - Over ten new Class II medical device products were launched in 2025, with details available on the company's official e-commerce platforms [3] Group 4: Mergers and Acquisitions - The company is monitoring potential mergers and acquisitions to enhance R&D capabilities and product matrix, with future developments to be disclosed in accordance with regulatory requirements [3] Group 5: Financial Guidance and Dividend Plans - The company has set internal sales plans for 2026 but will not publicly disclose annual performance forecasts [3] - The dividend plan for this year is yet to be determined, pending the evaluation of 2025 performance and 2026 funding plans, with an announcement expected on April 23, 2026 [3]